Cargando…
Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660173/ https://www.ncbi.nlm.nih.gov/pubmed/34949501 http://dx.doi.org/10.1016/j.jfo.2021.11.003 |
| _version_ | 1784613132068454400 |
|---|---|
| author | Delbarre, M. Maréchal, M. Froussart-Maille, F. |
| author_facet | Delbarre, M. Maréchal, M. Froussart-Maille, F. |
| author_sort | Delbarre, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8660173 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86601732021-12-10 Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report Delbarre, M. Maréchal, M. Froussart-Maille, F. J Fr Ophtalmol Letter to the Editor Elsevier Masson SAS. 2022-01 2021-12-10 /pmc/articles/PMC8660173/ /pubmed/34949501 http://dx.doi.org/10.1016/j.jfo.2021.11.003 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Delbarre, M. Maréchal, M. Froussart-Maille, F. Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title | Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_full | Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_fullStr | Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_full_unstemmed | Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_short | Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_sort | central serous chorioretinopathy following pfizer-biontech covid-19 vaccine: a case report |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660173/ https://www.ncbi.nlm.nih.gov/pubmed/34949501 http://dx.doi.org/10.1016/j.jfo.2021.11.003 |
| work_keys_str_mv | AT delbarrem centralserouschorioretinopathyfollowingpfizerbiontechcovid19vaccineacasereport AT marechalm centralserouschorioretinopathyfollowingpfizerbiontechcovid19vaccineacasereport AT froussartmaillef centralserouschorioretinopathyfollowingpfizerbiontechcovid19vaccineacasereport |